Trial · NCT03143153
Adverse events1,212
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,212
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Arm A: Nivolumab + Ipilimumab | 84 | 322 | |
| other | Anaemia | Blood and lymphatic system disorders | Arm B: Nivolumab + Chemotherapy | 156 | 310 | |
| other | Anaemia | Blood and lymphatic system disorders | Arm C: Chemotherapy | 108 | 304 | |
| other | Neutropenia | Blood and lymphatic system disorders | Arm A: Nivolumab + Ipilimumab | 6 | 322 | |
| other | Neutropenia | Blood and lymphatic system disorders | Arm B: Nivolumab + Chemotherapy | 38 | 310 | |
| other | Neutropenia | Blood and lymphatic system disorders | Arm C: Chemotherapy | 23 | 304 | |
| other | Hyperthyroidism | Endocrine disorders | Arm A: Nivolumab + Ipilimumab | 20 | 322 | |
| other | Hyperthyroidism | Endocrine disorders | Arm B: Nivolumab + Chemotherapy | 7 | 310 | |
| other | Hyperthyroidism | Endocrine disorders | Arm C: Chemotherapy | 1 | 304 | |
| other | Hypothyroidism | Endocrine disorders | Arm A: Nivolumab + Ipilimumab | 44 | 322 | |
| other | Hypothyroidism | Endocrine disorders | Arm B: Nivolumab + Chemotherapy | 23 | 310 | |
| other | Hypothyroidism | Endocrine disorders | Arm C: Chemotherapy | 1 | 304 | |
| other | Abdominal pain | Gastrointestinal disorders | Arm A: Nivolumab + Ipilimumab | 22 | 322 | |
| other | Abdominal pain | Gastrointestinal disorders | Arm B: Nivolumab + Chemotherapy | 23 | 310 | |
| other | Abdominal pain | Gastrointestinal disorders | Arm C: Chemotherapy | 18 | 304 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Arm A: Nivolumab + Ipilimumab | 16 | 322 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Arm B: Nivolumab + Chemotherapy | 22 | 310 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Arm C: Chemotherapy | 13 | 304 | |
| other | Constipation | Gastrointestinal disorders | Arm A: Nivolumab + Ipilimumab | 87 | 322 | |
| other | Constipation | Gastrointestinal disorders | Arm B: Nivolumab + Chemotherapy | 142 | 310 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03143153/events